It's all about H&N
While I do find the lastest news interesting it will have no effect on the stock, they will have to run it through the trials, so it's years away. Even the NSCLC trial was a sideshow an important one but if we get approved in Head and Neck we will make a lot of money.
Lately I was almost amused by the posts on Yahoo of that Mayor in Ohio who claimed a good result with reolysin in pancreatic. It was a niice story but anecdotal evidence does not impress me anymore, patients are notoriously overly optimistic with their treatments which is good thing for their mental health.
I see only two news events that could affect us before the first results in head and neck and that is the Squamous cell lung trial and possible one of the pancreatic trials.